Geffken resigns as TKTX CFO

Transkaryotic Therapies (TKTX) said Daniel Geffken resigned as SVP of finance and CFO. Last month, TKTX reduced its workforce to 346 from 446 employees as part of strategy to focus its R&D efforts on ...